SimBioSys, Inc.
Explore this company’s associated devices, FDA decisions and regulatory history.

SimBioSys, Inc.
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name SimBioSys, Inc.. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Sep 25, 2026 to Sep 25, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code SHW appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 320 N Sangamon St., Suite 700, Chicago, IL, 60607, US. Recorded on K260023, decision dated Sep 25, 2026.
Device categories in this collection
Pathology Software Algorithm Device Analyzing Digital Images For Breast Cancer Prognosis.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
TumorSight RiskK260023 | SimBioSys, Inc. | 510(k) clearance | Sep 25, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 20, 2026.
